Ignite Creation Date:
2025-12-24 @ 8:02 PM
Ignite Modification Date:
2026-01-02 @ 5:12 AM
Study NCT ID:
NCT05495204
Status:
COMPLETED
Last Update Posted:
2023-09-07
First Post:
2022-08-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
External Comparison of Ibalizumab in Trials vs. Other Regimens in OPERA
Sponsor:
Epividian
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
COL2022-001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None